Literature DB >> 8847059

A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration--a clinicopathological study.

K Shirabe1, T Matsumata, T Maeda, N Sadanaga, H Kuwano, K Sugimachi.   

Abstract

In patients with hepatocellular carcinoma, a diffuse lymphocyte infiltration into the tumor has been reported to be a favorable prognostic factor. Nevertheless, the mechanism of the lymphocyte infiltration is still unknown and HLA-DR antigen expression, which is the cause of lymphocyte infiltration, has never to our knowledge been previously reported in such cases. The patient in this case had hepatocellular carcinoma with a diffuse lymphocytes infiltration into the tumor and was able to survive for 6 yrs and 11 months without any cancer recurrence. The tissue was studied using histologic and immunohistologic methods. Microscopically, lymphocytes infiltrate along the trabeculae of cancer cells. Immunohistochemically, such infiltrated lymphocytes are mainly T lymphocytes. No lysozyme positive cells were seen in the tumor. HLA-DR antigen was diffusely and strongly expressed on the endothelial cells in the tumor, however its expression was minimal on the endothelial cells in the non-cancerous parenchyma. T lymphocytes infiltrated selectively towards the HLA-DR antigen of the endothelial cells in the tumor and the inflammatory infiltrate may thus be related to a distinct category of patients with a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847059

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

1.  Spontaneous regression of hepatocellular carcinoma repeated 3 times with invasion of portal vein and inferior vena cava: report on a rare case.

Authors:  Hirokazu Komatsu; Satoshi Imamura; Tomoki Shimizu; Yuya Tsunoda; Tsuyoshi Ito; Jin Imai; Shuichi Nagakubo; Yuichi Morohoshi; Yuriko Fujita
Journal:  Clin J Gastroenterol       Date:  2011-12-09

2.  CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.

Authors:  Yunching Chen; Rakesh R Ramjiawan; Thomas Reiberger; Mei R Ng; Tai Hato; Yuhui Huang; Hiroki Ochiai; Shuji Kitahara; Elizabeth C Unan; Tejaswini P Reddy; Christopher Fan; Peigen Huang; Nabeel Bardeesy; Andrew X Zhu; Rakesh K Jain; Dan G Duda
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

Review 3.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management.

Authors:  Ken Shirabe; Takashi Motomura; Jun Muto; Takeo Toshima; Rumi Matono; Yohei Mano; Kazuki Takeishi; Hideki Ijichi; Noboru Harada; Hideaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2010-10-21       Impact factor: 3.402

4.  Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes in vivo and in vitro.

Authors:  Wen-Chao Wang; Zong-Qin Zhang; Peng-Peng Li; Jun-Yong Ma; Lei Chen; Hai-Hua Qian; Le-Hua Shi; Zheng-Feng Yin; Bin Sun; Xiao-Feng Zhang
Journal:  Cancer Biol Ther       Date:  2019-04-24       Impact factor: 4.742

5.  An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens.

Authors:  Bei Wang; Jin He; Chen Liu; Lung-Ji Chang
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

Review 6.  Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of the literature.

Authors:  Masahiro Shinoda; Yoshie Kadota; Hanako Tsujikawa; Yohei Masugi; Osamu Itano; Akihisa Ueno; Kisho Mihara; Taizo Hibi; Yuta Abe; Hiroshi Yagi; Minoru Kitago; Shigeyuki Kawachi; Akihiro Tanimoto; Michiie Sakamoto; Minoru Tanabe; Yuko Kitagawa
Journal:  World J Surg Oncol       Date:  2013-05-04       Impact factor: 2.754

7.  Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.

Authors:  Yi Fu; Xindong Wei; Qiuqin Han; Jiamei Le; Yujie Ma; Xinjie Lin; Yuhui Xu; Ning Liu; Xuan Wang; Xiaoni Kong; Jinyang Gu; Ying Tong; Hailong Wu
Journal:  BMC Cancer       Date:  2021-10-30       Impact factor: 4.430

Review 8.  Lymphoepithelioma-like hepatocellular carcinoma: A case report and brief review of literature.

Authors:  Jun-Ke Wang; Yan-Wen Jin; Hai-Jie Hu; Parbatraj Regmi; Wen-Jie Ma; Qin Yang; Fei Liu; Cong-Dun Ran; Fei Su; Er-Liang Zheng; Fu-Yu Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Very Rare Liver Neoplasm: Lymphoepithelioma-Like (LEL) Hepatocellular Carcinoma.

Authors:  Marcello Filotico; Valentina Moretti; Federica Floccari; Alessandro D'Amuri
Journal:  Case Rep Pathol       Date:  2018-09-06

Review 10.  Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review.

Authors:  Kai Zhang; Changcheng Tao; Zonggui Tao; Fan Wu; Songlin An; Jianxiong Wu; Weiqi Rong
Journal:  Diagn Pathol       Date:  2020-09-23       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.